- Home
- KROS vs GNK Comparison
KROS vs GNK Comparison
Compare KROS & GNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- GNK
- Stock Information
- Founded
- KROS 2015
- GNK 2004
- Country
- KROS United States
- GNK United States
- Employees
- KROS N/A
- GNK N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- GNK Marine Transportation
- Sector
- KROS Health Care
- GNK Consumer Discretionary
- Exchange
- KROS Nasdaq
- GNK Nasdaq
- Market Cap
- KROS 589.8M
- GNK 596.0M
- IPO Year
- KROS 2020
- GNK 2005
- Fundamental
- Price
- KROS $11.84
- GNK $14.37
- Analyst Decision
- KROS Buy
- GNK Strong Buy
- Analyst Count
- KROS 11
- GNK 5
- Target Price
- KROS $45.33
- GNK $24.20
- AVG Volume (30 Days)
- KROS 2.1M
- GNK 398.1K
- Earning Date
- KROS 02-26-2025
- GNK 02-19-2025
- Dividend Yield
- KROS N/A
- GNK 10.93%
- EPS Growth
- KROS N/A
- GNK 527.82
- EPS
- KROS N/A
- GNK 1.58
- Revenue
- KROS $651,000.00
- GNK $439,330,000.00
- Revenue This Year
- KROS $303.27
- GNK $7.38
- Revenue Next Year
- KROS N/A
- GNK N/A
- P/E Ratio
- KROS N/A
- GNK $9.07
- Revenue Growth
- KROS 8037.50
- GNK 11.14
- 52 Week Low
- KROS $9.78
- GNK $13.51
- 52 Week High
- KROS $73.00
- GNK $23.43
- Technical
- Relative Strength Index (RSI)
- KROS 24.87
- GNK 47.56
- Support Level
- KROS $10.95
- GNK $13.93
- Resistance Level
- KROS $11.63
- GNK $14.54
- Average True Range (ATR)
- KROS 0.87
- GNK 0.41
- MACD
- KROS 1.31
- GNK 0.08
- Stochastic Oscillator
- KROS 30.60
- GNK 63.68
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters.